Clinical features of
Setting: About 1–3% of patients with diagnosed chronic obstructive pulmonary disease (COPD) is predicted to have alpha1-antitrypsin deficiency (A1ATD). Objective: To clinically evaluate and increase recognition of AATD in patients with COPD. Materials and methods: Sixty COPD patients were diagnosed...
Main Authors: | M. Sh. Badawy, A.F. El Qarn, H.A. Mohamadeen |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2013-01-01
|
Series: | Egyptian Journal of Chest Disease and Tuberculosis |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0422763813001015 |
Similar Items
-
Alpha 1 antitrypsin deficiency in non cystic fibrosis bronchiectasis
by: Mohamed Shahat Badawy, et al.
Published: (2013-04-01) -
Does urinary peptide content differ between COPD patients with and without inherited alpha-1 antitrypsin deficiency?
by: Carleo A, et al.
Published: (2017-03-01) -
Patterns and characterization of COPD exacerbations using real-time data collection
by: Ejiofor SI, et al.
Published: (2017-01-01) -
Individualized lung function trends in alpha-1-antitrypsin deficiency: a need for patience in order to provide patient centered management?
by: Stockley RA, et al.
Published: (2016-08-01) -
Detection of alpha-1 antitrypsin deficiency: the past, present and future
by: Mark Brantly, et al.
Published: (2020-04-01)